Tag:
Xiaflex
Latest Headlines
Latest Headlines
Swiss biotech Actelion grabs rights to biologic in $68.5M deal
With plans to beef up its limited commercial offerings, Swiss biotech Actelion ( $ATLN ) has secured rights in certain countries to Auxilium's ( $AUXL ) biotech drug for treating tissue buildups...
Auxilium readies sales force on FDA Xiaflex approval
As expected, the FDA has formally approved Auxilium Pharmaceuticals' Xiaflex, the first drug to get a green light to treat Dupuytren's contracture, a crippling buildup of collagen that freezes hands
FDA panel backs Auxilium's Xiaflex therapy
Auxilium Pharmaceuticals won the unanimous backing of an FDA advisory panel for its experimental therapy to treat Dupuytren's contracture. The panel said that Xiaflex is a safe and effective
Auxilium's xiaflex BLA granted priority review
PA-based Auxilium Pharmaceuticals announced today that the FDA has accepted its biologics license application for Xiaflex and granted the submission priority review. Xiaflex is a first-in-class
